The pilot program marks a paradigm shift in the federal government's relationship with the hemp industry and cannabis sativa products.
CMS finalizes 2027 Medicare Advantage and Part D rule with changes to star ratings, supplemental benefits, and Part D coverage effective June 1.
CMS wants “to turn this shoddy patchwork of care into a seamless tapestry,” write CMS Administrator Mehmet Oz and Center for ...
The Centers for Medicare & Medicaid Services April 1 released a final rule on policy and technical changes to Medicare Advantage, the Medicare Prescription Drug Benefit Program, Medicare Cost Plan ...
Patients enrolled in select federal health insurance programs could have up to $500 of hemp-derived products covered each ...
Information from CMS’s published explanations of the Medicare Drug Price Negotiation Program negotiated prices for 2027 will ...
Speakers at the 2026 National Investment Center for Seniors Housing & Care Spring Conference on Tuesday shared several new ...
Mary's Medicinals, a subsidiary of MM Brands Inc. (MM Brands), officially announced today its intent to participate in the newly established Centers for Medicare & Medicaid Services (CMS) cannabinoid ...
The government wants to save money by eliminating fraud and waste, but AARP and older adults are concerned the efforts block ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results